Collegium Pharmaceutical (COLL) Prepaid Assets (2014 - 2026)
Collegium Pharmaceutical's (COLL) quarterly Prepaid Assets came in at $32.6 million in Q1 2026, down 25.99% year-on-year from $44.0 million in Q1 2025, and little changed quarter-over-quarter from $32.6 million in Q4 2025.
Collegium Pharmaceutical (COLL) Prepaid Assets (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Prepaid Assets history runs 13 years deep, the most recent figure standing at $32.6 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 25.99% year-over-year to $32.6 million in Q1 2026; TTM through Mar 2026 was $32.6 million, a 25.99% decrease from a year earlier, with the FY2025 full-year figure at $32.6 million, up 1090.44% from the prior year.
- Prepaid Assets steadied at $32.6 million in Q1 2026 per COLL's latest filing, from $32.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $56.0 million in Q2 2025 and bottomed at $672000.0 in Q4 2023.
- The 5-year median for Prepaid Assets is $16.8 million (2023), against an average of $22.4 million.
- Across the five-year window, Prepaid Assets slumped 95.97% in 2023 and surged 1090.44% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $16.7 million in 2022, then slumped by 95.97% to $672000.0 in 2023, then surged by 308.04% to $2.7 million in 2024, then jumped by 1090.44% to $32.6 million in 2025, then dropped by 0.25% to $32.6 million in 2026.
- Per Business Quant, the three latest COLL Prepaid Assets figures stand at $32.6 million (Q1 2026), $32.6 million (Q4 2025), and $36.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.56 Mn |
| Dec 31, 2025 | 32.64 Mn |
| Sep 30, 2025 | 36.16 Mn |
| Jun 30, 2025 | 56.04 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 32.37 Mn |
| Jun 30, 2024 | 26.85 Mn |
| Mar 31, 2024 | 15.24 Mn |
| Dec 31, 2023 | 672,000.00 |
| Sep 30, 2023 | 16.55 Mn |
| Jun 30, 2023 | 18.32 Mn |
| Mar 31, 2023 | 16.80 Mn |
| Dec 31, 2022 | 16.68 Mn |
| Sep 30, 2022 | 11.04 Mn |
| Jun 30, 2022 | 11.78 Mn |
| Mar 31, 2022 | 10.45 Mn |
| Dec 31, 2021 | 5.88 Mn |
| Sep 30, 2021 | 3.64 Mn |
| Jun 30, 2021 | 6.07 Mn |